Trials / Withdrawn
WithdrawnNCT02183194
Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts
A Prospective, MultiCenter, Single-arm, Post-market Study of Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts (ACCESS)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Lutonix® 035 Drug Coated Balloon PTA Catheter (CE mark) for use as intended in the treatment of subjects with clinically significant hemodialysis vascular access stenosis or occlusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lutonix Paclitaxel Drug Coated Balloon |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-07-08
- Last updated
- 2016-02-02
Locations
4 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT02183194. Inclusion in this directory is not an endorsement.